Eurofins-Cerep SA
Research Eurofins-Cerep SA (ALECR) on Bullrun: market cap EUR 77.17M, P/E 16.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALECR
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 77.17M
- P/E16.1
- Financial periodFY2024
- RevenueEUR 40.46M
- Revenue growth-8.2%
- Net incomeEUR 7.15M
- Gross margin43.1%
Valuation Snapshot
latest market cap is EUR 77.17M; P/E is 16.1.
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.
Frequently asked questions
What is Eurofins-Cerep SA's market cap?
Eurofins-Cerep SA's market capitalization is EUR 77.17M.
What is Eurofins-Cerep SA's P/E ratio?
Eurofins-Cerep SA's price-to-earnings (P/E) ratio is 16.1.
What does Eurofins-Cerep SA do?
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling.